NanoString Technologies Market Cap 2011-2018 | NSTG

NanoString Technologies market cap history and chart from 2011 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. NanoString Technologies market cap as of March 25, 2019 is $0.73B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.726B $0.107B
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $137.409B 27.16
Medtronic (MDT) Ireland $121.535B 17.77
Stryker (SYK) United States $72.819B 26.70
Boston Scientific (BSX) United States $52.168B 25.43
Baxter (BAX) United States $39.788B 25.45
Zimmer Biomet Holdings (ZBH) United States $25.879B 16.57
Smith & Nephew SNATS (SNN) United Kingdom $17.424B 0.00
Canopy Growth (CGC) Canada $14.802B 0.00
ResMed (RMD) United States $14.533B 27.56
Aurora Cannabis (ACB) Canada $9.364B 66.07
Bio-Rad Laboratories (BIO) United States $9.204B 52.51
Hill-Rom Holdings (HRC) United States $6.966B 21.55
Perrigo (PRGO) Ireland $6.355B 10.30
Insulet (PODD) United States $5.761B 1943.60
GW Pharmaceuticals (GWPH) United Kingdom $4.977B 0.00
ICU Medical (ICUI) United States $4.744B 29.53
Haemonetics (HAE) United States $4.355B 38.63
Hutchison China MediTech (HCM) China $3.802B 0.00
Agios Pharmaceuticals (AGIO) United States $3.664B 0.00
Neogen (NEOG) United States $3.153B 48.42
NuVasive (NUVA) United States $2.938B 25.63
Quidel (QDEL) United States $2.527B 22.80
Aphria (APHA) $2.418B 107.33
National Vision Holdings (EYE) United States $2.298B 45.20
Cardiovascular Systems (CSII) United States $1.337B 960.00
HEXO (HEXO) $1.317B 0.00
VAREX IMAGING (VREX) United States $1.274B 24.95
Phibro Animal Health (PAHC) United States $1.273B 18.29
AtriCure (ATRC) United States $1.095B 0.00
MacroGenics (MGNX) United States $0.957B 0.00
Lantheus Holdings (LNTH) United States $0.914B 24.70
Cerus (CERS) United States $0.842B 0.00
Omeros (OMER) United States $0.836B 0.00
PetIQ (PETQ) United States $0.835B 23.90
Meridian Bioscience (VIVO) United States $0.716B 21.32
Eagle Pharmaceuticals (EGRX) United States $0.674B 22.95
OraSure Technologies (OSUR) United States $0.671B 29.41
TG Therapeutics (TGTX) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.587B 27.92
Evolus (EOLS) United States $0.577B 0.00
Surmodics (SRDX) United States $0.556B 80.90
Quanterix (QTRX) United States $0.531B 0.00
BioLife Solutions (BLFS) United States $0.350B 144.46
Insys Therapeutics (INSY) United States $0.342B 0.00
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.325B 0.00
Utah Medical Products (UTMD) United States $0.313B 20.33
Bovie Medical (APYX) United States $0.271B 0.00
Owens & Minor (OMI) United States $0.265B 3.67
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.242B 0.00
Cytosorbents (CTSO) United States $0.237B 0.00
Zynex (ZYXI) United States $0.142B 15.21
Fonar (FONR) United States $0.140B 7.48
Surface Oncology (SURF) United States $0.123B 0.00
Chimerix (CMRX) United States $0.103B 0.00
Female Health (VERU) United States $0.097B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
InfuSystems Holdings (INFU) United States $0.089B 0.00
United-Guardian (UG) United States $0.087B 20.02
CAS Medical Systems (CASM) United States $0.071B 0.00
Neurotrope (NTRP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 18.50
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.033B 0.00
Senestech (SNES) United States $0.032B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14